Overview
PNR market data
Price History
PNR price chart · 1M
- O
- 59.56
- H
- 60.31
- L
- 59.19
- C
- 60.21
- Vol
- 123,861.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $59.56
- Previous Close
- $60.00
- Day High
- $60.31
- Day Low
- $59.19
- 52 Week High
- $77.55
- 52 Week Low
- $59.19
- 7 Day Return
- -2.55%
- 30 Day Return
- -12.78%
- 90 Day Return
- -16.84%
- 1 Year Return
- -20.23%
- Daily Notional Volume
- $7.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 14.76 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.95 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.04 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.4% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 16.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $57.60 – $113.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9.6B · P/B 4.40 · P/S 2.40.
Company News
10 captured
Kaplan Fox Reminds Investors of a Securities Class Action Against UWM Holdings Corporation (NYSE: UWMC) – Deadline is October 13, 2026Globenewswire Inc ·
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership RoleGlobenewswire Inc ·
CORRECTION: Pentair Q2 Adj. EPS $1.14 Misses $1.22 Estimate, Sales $932.600M Miss $958.064M EstimateBenzinga ·
Pentair Sees Q3 Adj EPS $1.05-$1.08 vs $1.20 Est; Sees Sales $960.680M-$981.120M vs $980.893M EstBenzinga ·
8-K filing — PENTAIR plc (PNR)SEC EDGAR ·